Rosuvastatin Completed Phase 3 Trials for Atherosclerosis Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00115830Rho Kinase in Patients With Atherosclerosis
NCT01936805ROsuvastatin LOading and Clinical Outcomes Trial
NCT02546323A phase3 Study Measuring the Effect of Rosuvastatin 20 mg on Carotid Intima-Media Thickness in Chinese Subjects With Subclinical Atherosclerosis